Live Breaking News & Updates on Helen Walden

Stay updated with breaking news from Helen walden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field

Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced it is supporting a Master’s student at the University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neurodegenerative, renal, and cardiovascular diseases. ....

Mehmet Gundogdu , Niyati Gupta Kheskani , Helen Walden , University Of Glasgow Uo , University Of Glasgow , Ubiquigent Limited , Head Of School Molecular Biosciences , Professor Helen Walden , Principal Scientist , Structural Biology , Molecular Biosciences , Professor Walden , Sheelagh Frame , Chief Scientific Officer , Drug Discovery , Structural Biology , N Vitro , Research Project ,

Ubiquigent appoints Dr Xavier Jacq to Scientific Advisory Board

Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced the appointment of Dr Xavier Jacq to its Scientific Advisory Board (SAB). ....

United States , Philip Cohen , John Davis , Helen Walden , Xavier Jacq , Mission Therapeutics , Cancer Biology At Colombia University , Louis Pasteur University In Strasbourg , Ubiquigent Limited , Vp Scientific Affairs , Scientific Advisory Board , Professor Sir Philip , Almac Discovery , Dunad Therapeutics , Senior Vice , Chief Scientific Officer , Louis Pasteur University , Cancer Biology , Colombia University , Drug Discovery ,